Advertisements


Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights

50% of Enrollment Complete for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Results from RECOVERY Interim Analysis Expected First Quarter 2020 Topline Data Expected Second Quarter 2020 Based on Cu.....»»

Category: earningsSource: benzingaNov 8th, 2019

Tonix Pharmaceuticals Reports Second Quarter 2019 Financial Results and Operational Highlights

Enrollment Continues for Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD; Topline Data Expected First Half of 2020 Pipeline Expanded in Addiction Medicine with Cocaine .....»»

Category: earningsSource: benzingaAug 12th, 2019

Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2019 Financial Results and Operational Highlights.....»»

Category: earningsSource: benzingaMay 13th, 2019

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights

Phase 3 RECOVERY Trial of Tonmya® for the .....»»

Category: earningsSource: benzingaMar 18th, 2019

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights

DEVON, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innova.....»»

Category: earningsSource: benzingaMar 11th, 2019

Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2018 Financial Results and Operational Highlights

DEVON, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pha.....»»

Category: earningsSource: benzingaMar 11th, 2019

RedHill Biopharma Reports Third Quarter 2019 Financial Results and Operational Highlights

RedHill Biopharma Reports Third Quarter 2019 Financial Results and Operational Highlights.....»»

Category: earningsSource: benzingaNov 19th, 2019

Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights

- Continued execution on transition to a new business model from contract manufacturer to biopharmaceutical company - - Maintai.....»»

Category: earningsSource: benzingaNov 13th, 2019

Spring Bank Pharmaceuticals Reports Third Quarter 2019 Financial and Operational Results and Provides Corporate Update

HOPKINTON, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammato.....»»

Category: earningsSource: benzingaNov 7th, 2019

Ceapro Inc. Reports 2019 Second Quarter and Six-Month Financial Results and Operational Highlights

- Continued execution on transition to a new business model from contract manufacturer to biopharmaceutical compan.....»»

Category: earningsSource: benzingaAug 28th, 2019

Brainsway Reports Second Quarter 2019 Financial Results and Operational Highlights

JERUSALEM, Israel and HACKENSACK, N.J., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd. (NASDAQ & TASE: BWAY) ("Brainsway" or the "Company"), a global leader in the advanced non-invasive treatment of brain disorders, today reporte.....»»

Category: earningsSource: benzingaAug 26th, 2019

Precision BioSciences Reports Second Quarter 2019 Financial Results and Highlights Ongoing Operational Progress

DURHAM, N.C., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (NASDAQ:DTIL) ("Precision"), a genome editing company dedicated to improving life through the application of its p.....»»

Category: earningsSource: benzingaAug 14th, 2019

Ionis Reports Second Quarter 2019 Financial Results

CARLSBAD, Calif., Aug. 7, 2019 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) today reported its financial results for the second quarter and year-to-date 2019 and recent business highlights. "We ente.....»»

Category: earningsSource: benzingaAug 7th, 2019

Spring Bank Pharmaceuticals Reports Second Quarter 2019 Financial and Operational Results and Provides Business Development Update

HOPKINTON, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biop.....»»

Category: earningsSource: benzingaJul 31st, 2019

Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights

Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights.....»»

Category: earningsSource: benzingaMay 14th, 2019

Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights

Company reports first quarter 2019 total revenues of $4.5 million. XHANCE first quarter net product revenu.....»»

Category: earningsSource: benzingaMay 9th, 2019

Synthetic Biologics Reports First Quarter 2019 Operational Highlights and Financial Results

ROCKVILLE, Md., May 8, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE:SYN), a late-stage clinical company developing therapeutics that prese.....»»

Category: earningsSource: benzingaMay 8th, 2019

Chesapeake Energy Corporation Reports 2019 First Quarter Financial And Operational Results

OKLAHOMA CITY, May 8, 2019 /PRNewswire/ -- Chesapeake Energy Corporation (NYSE:CHK) today reported financial and operational results for the 2019 first quarter. Highlights include: Early Brazos Valley (BVL) .....»»

Category: earningsSource: benzingaMay 8th, 2019

MEG Energy reports strong adjusted funds flow in first quarter 2019

All financial figures in Canadian dollars ($ or C$) unless otherwise noted CALGARY, May 6, 2019 /CNW/ - MEG Energy Corp. ("MEG") reported its first quarter 2019 operational and financial results. Highlights .....»»

Category: earningsSource: benzingaMay 6th, 2019

Spring Bank Pharmaceuticals Reports First Quarter 2019 Financial and Operational Results and Provides Corporate Update

ACHIEVE trial completed – inarigivir HBsAg reduction comparable to interferon but with significantly better tolerability profile Phase 2 co-administration study of inarigi.....»»

Category: earningsSource: benzingaApr 29th, 2019

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Business Progress

DEER PARK, Ill., March 25, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ:ETON), a spe.....»»

Category: earningsSource: benzingaMar 25th, 2019